Door to Balloon Time of Non-ST Elevation Myocardial Infarction May be Reconsidered According to Systemic Immune-Inflammation Index

Aim    Early diagnosis and treatment is very important in acute coronary syndromes (ACS). Previous studies showed that not all non-ST elevation myocardial infarction (NSTEMI) patients should be considered and treated in the same way. The systemic immune-inflammation index (SII), which is an easily accessible, rapidly computed, and cost-effective parameter, was evaluated in this study to determine the optimal intervention time for NSTEMI.
Material and methods    469 patients diagnosed with ACS were included to the study. STEMI and NSTEMI patients were compared according to their SII. Univariate and binary logistic regression analysis were performed to determine which parameters have a significant effect on the discrimination of types of myocardial infarction.
Results    The mean age of the patients was 61.43±11.52 yrs, and 348 (74.2 %) were male. NSTEMI patients with an SII value higher than 768×109 / l may be assumed to be STEMI (p<0.001). Univariate analysis and binary logistic regression showed that only SII and hypertension had statistically impact on differentiation of STEMI and NSTEMI. In addition, SII value of 1105×109 / l was the cut-off point for discrimination of cardiovascular survival (p<0.001, AUC =0.741). This study was performed to find out which NSTEMI patients should be treated percutaneously immediately after first medical contact according to SII. It was found that, SII value of higher than 768×109 / l is related with STEMI.
Conclusion    In conclusion, NSTEMI patients with a SII value higher than 768×109 / l may be considered as STEMI and treated with in 120 min after first contact. In addition, SII was found to be a cardiovascular mortality predictor after myocardial infarction, and this may be used for identifying high-risk patients after percutaneous coronary intervention.

1. Naghavi M, Abajobir AA, Abbafati C, Abbas KM, Abd-Allah F, Abera SF et al. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 2017;390(10100):1151–210. DOI: 10.1016/S0140-6736(17)32152-9

2. Li N, Ma J, Liu F, Zhang Y, Ma P, Jin Y et al. Associations of apparent temperature with acute cardiac events and subtypes of acute coronary syndromes in Beijing, China. Scientific Reports. 2021;11(1):15229. DOI: 10.1038/s41598-021-94738-9

3. Collet J-P, Thiele H, Barbato E, Barthélémy O, Bauersachs J, Bhatt DL et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. European Heart Journal. 2021;42(14):1289–367. DOI: 10.1093/eurheartj/ehaa575

4. Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). European Heart Journal. 2018;39(2):119–77. DOI: 10.1093/eurheartj/ehx393

5. Nable JV, Brady W. The evolution of electrocardiographic changes in ST-segment elevation myocardial infarction. The American Journal of Emergency Medicine. 2009;27(6):734–46. DOI: 10.1016/j.ajem.2008.05.025

6. Aslanger EK, Yıldırımtürk Ö, Şimşek B, Bozbeyoğlu E, Şimşek MA, Yücel Karabay C et al. DIagnostic accuracy oF electrocardiogram for acute coronary OCClUsion resuLTing in myocardial infarction (DIFOCCULT Study). IJC Heart & Vasculature. 2020;30:100603. DOI: 10.1016/j.ijcha.2020.100603

7. Smith SW, Khalil A, Henry TD, Rosas M, Chang RJ, Heller K et al. Electrocardiographic Differentiation of Early Repolarization From Subtle Anterior ST-Segment Elevation Myocardial Infarction. Annals of Emergency Medicine. 2012;60(1):45-56.e2. DOI: 10.1016/j.annemergmed.2012.02.015

8. Yang Y, Wu C, Hsu P, Chen S, Huang S, Chan WL et al. Systemic immune-inflammation index (SII) predicted clinical outcome in patients with coronary artery disease. European Journal of Clinical Investigation. 2020;50(5):e13230. DOI: 10.1111/eci.13230

9. Chen J-H, Zhai E-T, Yuan Y-J, Wu K-M, Xu J-B, Peng J-J et al. Systemic immune-inflammation index for predicting prognosis of colorectal cancer. World Journal of Gastroenterology. 2017;23(34):6261–72. DOI: 10.3748/wjg.v23.i34.6261

10. Geraghty JR, Lung TJ, Hirsch Y, Katz EA, Cheng T, Saini NS et al. Systemic Immune-Inflammation Index Predicts Delayed Cerebral Vasospasm After Aneurysmal Subarachnoid Hemorrhage. Neurosurgery. 2021;89(6):1071–9. DOI: 10.1093/neuros/nyab354

11. Öcal L, Keskin M, Cerşit S, Eren H, Özgün Çakmak E, Karagöz A et al. Systemic immune-inflammation index predicts in-hospital and long-term outcomes in patients with ST-segment elevation myocardial infarction. Coronary Artery Disease. 2022;33(4):251–60. DOI: 10.1097/MCA.0000000000001117

12. Protocol for the Bypass Angioplasty Revascularization Investigation. Circulation. 1991;84(6 Suppl):V1–28

13. Goksuluk D, Korkmaz S, Zararsiz G, Karaagaoglu A Ergun. easyROC: An Interactive Web-tool for ROC Curve Analysis Using R Language Environment. The R Journal. 2016;8(2):213. DOI: 10.32614/RJ-2016-042

14. Ino Y, Kubo T, Tanaka A, Kuroi A, Tsujioka H, Ikejima H et al. Difference of Culprit Lesion Morphologies Between ST-Segment Elevation Myocardial Infarction and Non–ST-Segment Elevation Acute Coronary Syndrome. JACC: Cardiovascular Interventions. 2011;4(1):76–82. DOI: 10.1016/j.jcin.2010.09.022

15. Iannaccone M, Quadri G, Taha S, D’Ascenzo F, Montefusco A, Omede’ P et al. Prevalence and predictors of culprit plaque rupture at OCT in patients with coronary artery disease: a meta-analysis. European Heart Journal – Cardiovascular Imaging. 2016;17(10):1128–37. DOI: 10.1093/ehjci/jev283

16. Karwowski J, Gierlotka M, Gąsior M, Poloński L, Ciszewski J, Bęćkowski M et al. Relationship between infarct artery location, acute total coronary occlusion, and mortality in STEMI and NSTEMI patients. Polish Archives of Internal Medicine. 2017;127(6):401–11. DOI: 10.20452/pamw.4018

17. Khan AR, Golwala H, Tripathi A, Bin Abdulhak AA, Bavishi C, Riaz H et al. Impact of total occlusion of culprit artery in acute non-ST elevation myocardial infarction: a systematic review and meta-analysis. European Heart Journal. 2017;38(41):3082–9. DOI: 10.1093/eurheartj/ehx418

18. Phibbs B, Nelson W. Differential classification of acute myocardial infarction into ST- and non-ST segment elevation is not valid or rational. Annals of Noninvasive Electrocardiology. 2010;15(3):191–9. DOI: 10.1111/j.1542-474X.2010.00377.x

19. Miranda DF, Lobo AS, Walsh B, Sandoval Y, Smith SW. New Insights Into the Use of the 12-Lead Electrocardiogram for Diagnosing Acute Myocardial Infarction in the Emergency Department. Canadian Journal of Cardiology. 2018;34(2):132–45. DOI: 10.1016/j.cjca.2017.11.011

20. Trtica Majnarić L, Guljaš S, Bosnić Z, Šerić V, Wittlinger T. Neutrophil-to-Lymphocyte Ratio as a Cardiovascular Risk Marker May Be Less Efficient in Women Than in Men. Biomolecules. 2021;11(4):528. DOI: 10.3390/biom11040528

21. Wada H, Dohi T, Miyauchi K, Nishio R, Takeuchi M, Takahashi N et al. Neutrophil to Lymphocyte Ratio and Long-Term Cardiovascular Outcomes in Coronary Artery Disease Patients with Low High-Sensitivity C-Reactive Protein Level. International Heart Journal. 2020;61(3):447–53. DOI: 10.1536/ihj.19-543

22. Saskin H, Ozcan KS, Duzyol C, Baris O, Koçoğulları UC. Are inflammatory parameters predictors of amputation in acute arterial occlusions? Vascular. 2017;25(2):170–7. DOI: 10.1177/1708538116652995

23. Ozgeyik M, Ozgeyik MO. Long-term Prognosis after Treatment of Total Occluded Coronary Artery is well Predicted by Neutrophil to High-Density Lipoprotein Ratio: a Comparison Study. Kardiologiia. 2021;61(7):60–7. DOI: 10.18087/cardio.2021.7.n1637

24. Taghizadeh E, Taheri F, Gheibi Hayat SM, Montecucco F, Carbone F, Rostami D et al. The atherogenic role of immune cells in familial hypercholesterolemia. IUBMB Life. 2020;72(4):782–9. DOI: 10.1002/iub.2179

25. Migeotte I, Communi D, Parmentier M. Formyl peptide receptors: A promiscuous subfamily of G protein-coupled receptors controlling immune responses. Cytokine & Growth Factor Reviews. 2006;17(6):501–19. DOI: 10.1016/j.cytogfr.2006.09.009

26. Malle E, Marsche G, Arnhold J, Davies MJ. Modification of low-densi- ty lipoprotein by myeloperoxidase-derived oxidants and reagent hypo- chlorous acid. Biochimica et Biophysica Acta. 2006;1761(4):392–415. DOI: 10.1016/j.bbalip.2006.03.024

27. Jerke U, Rolle S, Purfürst B, Luft FC, Nauseef WM, Kettritz R. β2 Integrin-mediated Cell-Cell Contact Transfers Active Myeloperoxidase from Neutrophils to Endothelial Cells. Journal of Biological Chemistry. 2013;288(18):12910–9. DOI: 10.1074/jbc.M112.434613

28. Hansson GK, Jonasson L. The Discovery of Cellular Immunity in the Atherosclerotic Plaque. Arteriosclerosis, Thrombosis, and Vascular Biology. 2009;29(11):1714–7. DOI: 10.1161/ATVBAHA.108.179713

29. Gu P, Fang Gao J, D’Souza CA, Kowalczyk A, Chou K-Y, Zhang L. Trogocytosis of CD80 and CD86 by induced regulatory T cells. Cellular & Molecular Immunology. 2012;9(2):136–46. DOI: 10.1038/cmi.2011.62

30. Pafili K, Penlioglou T, Mikhailidis DP, Papanas N. Mean platelet volume and coronary artery disease. Current Opinion in Cardiology. 2019;34(4):390–8. DOI: 10.1097/HCO.0000000000000624

31. Yilmaz MB, Cihan G, Guray Y, Guray U, Kisacik HL, Sasmaz H et al. Role of mean platelet volume in triagging acute coronary syndromes. Journal of Thrombosis and Thrombolysis. 2008;26(1):49–54. DOI: 10.1007/s11239-007-0078-9

32. Özkan U, Gürdoğan M, Öztürk C, Demir M, Akkuş ÖF, Yılmaz E et al. Systemic Immune-Inflammation Index: A Novel Predictor of Coronary Thrombus Burden in Patients with Non-ST Acute Coronary Syndrome. Medicina. 2022;58(2):143. DOI: 10.3390/medicina58020143